Table 1.
Target gene | Primers | Sequence | Fragment size (bp) |
---|---|---|---|
β-Actin | Forward | 5′-GGGCTGTATTCCCCTCCATCG-3′ | 201 |
Reverse | 5′-GCAGCTCATTGTAGAAGGTGTGGTG-3′ | ||
Rev-erbα | Forward | 5′-ATTCGGGAGGTGGTAGAGTTTGC-3′ | 148 |
Reverse | 5′-ATCACTGTCTGGTCCTTCACGTTG-3′ | ||
Bmal1 | Forward | 5′-AACCTTCCCGCAGCTAACAG-3′ | 79 |
Reverse | 5′-AGTCCTCTTTGGGCCACCTT-3′ | ||
Wnt3a | Forward | 5′-CTTAGTGCTCTGCAGCCTGA-3′ | 92 |
Reverse | 5′-GAGTGCTCAGAGAGGAGTACTGG-3′ | ||
β-Catenin | Forward | 5′-GGGTCCTCTGTGAACTTGCTC-3′ | 165 |
Reverse | 5′-TGTAATCCTGTGGCTTGTCCTC-3′ | ||
GSK-3β | Forward | 5′-CCTTATCCCTCCACATGCTCG-3′ | 103 |
Reverse | 5′-GTTATTGGTCTGTCCACGTCTC-3′ | ||
OSX | Forward | 5′-TGCCTACTTACCCATCTGACTT-3′ | 134 |
Reverse | 5′-TTGCCCACTATTGCCAACC-3′ | ||
ALP | Forward | 5′-CCCCCCGTGGCAACTCTATCTT-3′ | 272 |
Reverse | 5′-GTAGTTCTGCTCGTGGACGCCG-3′ | ||
BSP | Forward | 5′-CACAAGCAGACACTTTCACTCC-3′ | 77 |
Reverse | 5′-TCCATAAGCCAAGCTATCACC-3′ | ||
c-Myc | Forward | 5′-CTGTATGTGGAGCGGTTTCTC-3′ | 90 |
Reverse | 5′-AGGCTGGTGCTGTCTTTGC-3′ | ||
TCF1 | Forward | 5′-CTACAGCGACGAGCACTTTTCTC-3′ | 115 |
Reverse | 5′-GTAGAAGGTGGGGATTTCAGGAG-3′ |
ALP, alkaline phosphatase; BSP, bone sialoprotein; GSK, glycogen synthase kinase; OSX, Osterix; RT-PCR, reverse transcription–polymerase chain reaction; TCF, T cell factor.